000			01891 a2200565 4500
005			20250512133741.0
264		0	_c19710519
008			197105s 0 0 eng d
022			_a0026-0495
024	7		_a10.1016/0026-0495(71)90103-x _2doi
040			_aNLM _beng _cNLM
100	1		_aHerrold, J N
245	0	0	_aAcute and chronic studies using a new oral hypoglycemic agent, glyburide. _h[electronic resource]
260			_bMetabolism: clinical and experimental _cApr 1971
300			_a414-21 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650	0	4	_aAcute Disease
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlkaline Phosphatase _xurine
650	0	4	_aAspartate Aminotransferases _xblood
650	0	4	_aBilirubin _xurine
650	0	4	_aBlood Cell Count
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aBlood Urea Nitrogen
650	0	4	_aCholesterol _xblood
650	0	4	_aChronic Disease
650	0	4	_aClinical Trials as Topic
650	0	4	_aCyclohexanes _xadministration & dosage
650	0	4	_aDiabetes Mellitus _xblood
650	0	4	_aFemale
650	0	4	_aGlucose Tolerance Test
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin Secretion
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPancreas _xdrug effects
650	0	4	_aPhenformin _xtherapeutic use
650	0	4	_aPlacebos
650	0	4	_aSulfones _xadministration & dosage
650	0	4	_aThymol _xanalysis
650	0	4	_aUrea _xadministration & dosage
700	1		_aTzagournis, M
700	1		_aSkillman, T G
773	0		_tMetabolism: clinical and experimental _gvol. 20 _gno. 4 _gp. 414-21
856	4	0	_uhttps://doi.org/10.1016/0026-0495(71)90103-x _zAvailable from publisher's website
999			_c4930381 _d4930381